(Q46751730)

24 December 2017

title

Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine (English)

1 reference

24 December 2017

0 references

Ai-Ling Zhao

1

1 reference

24 December 2017

Jing-Ping Zhao

2

1 reference

24 December 2017

Yu-Hu Zhang

3

1 reference

24 December 2017

Zhi-Min Xue

4

1 reference

24 December 2017

Jin-Dong Chen

5

1 reference

24 December 2017

Xiao-Gang Chen

6

1 reference

24 December 2017

publication date

1 November 2005

1 reference

24 December 2017

International Journal of Neuroscience

published in

1 reference

24 December 2017

volume

115

1 reference

24 December 2017

page(s)

1539-1547

1 reference

24 December 2017

issue

11

1 reference

24 December 2017

DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

The two-syndrome concept: origins and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Multiple dopamine D4 receptor variants in the human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450590957863

10.1080/00207450590957863

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16223700

1 reference

24 December 2017